Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer
Trial ID or NCT#
Status
Purpose
The purpose of this study is to (1) describe patient and clinician engagement in web-based symptom self-monitoring, (2) identify differences in symptom management between intervention and usual care groups, and (3) identify potential outcomes of real-time symptom tracking and management. With the assistance of the study coordinator, participants randomized to the intervention will create an account with Noona. Patients will be instructed to log symptoms as often as relevant using their own personal devices. Patients will also be prompted once per week for 24 weeks to log any recent symptoms. These participants will be sent a Symptom Questionnaire (SQ) via the Noona tool that summarizes their symptoms and distress one week prior to each oncology clinic visit. Symptoms designated as clinically severe either during regular symptom logging or via the SQ will trigger a prompt to contact the clinical team for immediate follow-up.
Official Title
Digital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer
Eligibility Criteria
- 1. Individuals (men and women) aged 18 years or older2. Biopsy proven (recurrent or metastatic) advanced lung or gastrointestinal cancer3. No limit on prior lines of therapy in the metastatic setting4. ECOG performance status of 0-25. Estimated life expectancy of at least 6 months6. Access to smartphone, tablet or computer with capability to utilize symptom tracking application7. Willing and able to provide written, signed informed consent after the nature of the study has been explained, and prior to any ÌÇÐÄ´«Ã½-related procedures8. Willing and able to comply with all study procedures
- 1. Concurrent disease or condition that interferes with participation or safety2. Non-english speaking, as the application is developed in the english language3. Non-castrate resistant prostate cancer4. Enrolled in other non-therapeutic or therapeutic clinical trials
Investigator(s)
View on